Concepedia

Hideaki Karasawa

HK

Statistics

Publications

22

Citations

847

H-Index

18

Active since

2008

Affiliations

Tohoku University(Current)

Tohoku University Hospital

Center for Cancer Research

Tokyo Medical University Hachioji Medical Center

Frederick National Laboratory for Cancer Research

Hideaki Karasawa is an author at Tohoku University specializing in medicine, cancer research, and oncology.

ORCID

Top concepts

Publications per year

2008–2021

22

Publications

22

siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis

Naoyuki Kaneko, Koh Miura, Zhaodi Gu et al. · Biochemical and Biophysical Research Communications · 2009 · 87 citations

, , +9

Cancer‐associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer

Takashi Aizawa, Hideaki Karasawa, Ryo Funayama et al. · Cancer Medicine · 2019 · 84 citations · Full text

, , +18

Runt‐related transcription factor 2 in human colon carcinoma: A potent prognostic factor associated with estrogen receptor

Tomohiko Sase, Takashi Suzuki, Koh Miura et al. · International Journal of Cancer · 2012 · 62 citations · Full text

, , +18

<i>Cripto-1</i> as a novel therapeutic target for triple negative breast cancer

Nadia P. Castro, Natalie Abrams, Anand S. Merchant et al. · Oncotarget · 2014 · 59 citations · Full text

Down‐regulation of cIAP2 enhances 5‐FU sensitivity through the apoptotic pathway in human colon cancer cells

Hideaki Karasawa, Koh Miura, Wataru Fujibuchi et al. · Cancer Science · 2009 · 57 citations · Full text

1–5 of 22